Kala Bio KALA
NASDAQ KALA
$0.84 -0.06 (-6.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Kala Bio (KALA) EBIT Margin Growth (3y) (2022)

Kala Bio (KALA) EBIT Margin Growth (3y) (2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -204.00
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -537.00
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 9,003.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 30,461.00
8 Royalty Pharma 26.98 Bn 26.14 Bn - -2,649.00
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -11,254.00
10 Kala Bio 9.87 Mn 9.87 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -198,246.00
Jun 30, 2022 -14,731.00
Mar 31, 2022 -51,800.00